ClinicalTrials.govpublic full text
APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma
melanoma, metastatic melanoma, intratumoral apx005m, pembrolizumab, keytruda, mk-3475, sch-900475, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 914053
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.